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Abstract: Freezing of gait is one of the most debilitating symptoms of Parkinson’s disease and is an
important contributor to falls, leading to it being a major cause of hospitalization and nursing home
admissions. When the management of freezing episodes cannot be achieved through medication or
surgery, non-pharmacological methods such as cueing have received attention in recent years. Novel
cueing systems were developed over the last decade and have been evaluated predominantly in
laboratory settings. However, to provide benefit to people with Parkinson’s and improve their quality
of life, these systems must have the potential to be used at home as a self-administer intervention.
This paper aims to provide a technological review of the literature related to wearable cueing systems
and it focuses on current auditory, visual and somatosensory cueing systems, which may provide
a suitable intervention for use in home-based environments. The paper describes the technical
operation and effectiveness of the different cueing systems in overcoming freezing of gait. The “What
Works Clearinghouse (WWC)” tool was used to assess the quality of each study described. The paper
findings should prove instructive for further researchers looking to enhance the effectiveness of
future cueing systems.
Keywords: cueing; Freezing of Gait; FoG; Parkinson’s disease; wearable electronics
1. Introduction
Parkinson’s disease (PD) is characterized by four cardinal symptoms (bradykinesia, rigidity tremor
and postural instability) occurring due to the degeneration of dopamine-producing neurons [1,2].
One of the most debilitating symptoms of PD is Freezing of Gait (FoG), which is especially present
in more advanced stages of the disease [3]. FoG is defined as a “brief episodic absence or marked
reduction of forward progression of the feet despite the intention to walk” [4]. FoG is often described
by people with Parkinson’s (PwP) as having their feet “glued to the ground” [5]. Three forms of FoG
have been identified: a purely akinesia form (no motion of the person’s legs is observed); a “tremble in
place” form (inability of the person to step with their legs trembling at a frequency of 2 to 4 Hz) and a
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“shuffling” form (spontaneous increase in cadence and decrease in step length) [6,7]. Tremble in place
and shuffling are the most common forms of FoG, while total akinesia is rare [8]. The presence of FoG
is an important contributor to falls in PwP [9–11], and is a major cause of hospitalization and nursing
home admissions for this group [6,12,13]. This results in a huge personal strain on the PwP, including
their carer(s) and substantial economical strain on the health system. Beyond its direct effect on gait,
living with FoG has additional PD associated non-motor complications such as anxiety, social isolation
and depression and dramatically affects the person’s quality of life (QoL) [14–19].
The pathophysiology of FoG is complex and unclear, and despite limited understanding of
the disrupted physiological processes associated with FoG, a number of treatment options are
currently available. However, clinical consensus on a cohesive treatment protocol for FoG does
not exist [20,21]. FoG can also be categorized based on its responsiveness to dopaminergic medication
(Table 1) [22]. Although no large-scale studies on the prevalence of dopaminergic-responsive FoG
were reported, an observational multi-center study by Amboni et al. described 61.6% of 325 PwP
with FoG that only occurred in the off-medication state [23]. The primary treatment option for
dopaminergic-responsive FoG is to increase dopaminergic medication [3]. However, for some PwP,
increasing the dose of dopaminergic medication is often complicated by dose-limiting side-effects,
such as dopaminergic-induced dyskinesia [24]. Under these circumstances, surgical procedures such
as pump-delivered therapies and deep brain stimulation (DBS) of the subthalamic nucleus (STN) may
become an effective treatment option [21].
Table 1. Freezing of Gait (FoG) subtypes and response to dopaminergic medication.
FoG Subtype Off-Medication State On-Medication State
Dopaminergic-Responsive FoG FoG Occurs No FoG
Dopaminergic-Induced FoG No FoG FoG Occurs
Dopaminergic-Resistant FoG FoG Occurs FoG Occurs
Dopaminergic-induced FoG is uncommon and in the case of Amboni et al. only 1.8% of the
325 PwP had FoG that only occurred in the on-medication state [23]. The primary treatment option
for dopaminergic-induced FoG is to reduce dopaminergic medication [3]. However, the reduction of
dopaminergic medication is impossible for some PwP, due to unacceptable worsening of the cardinal
symptoms of PD. Under these circumstances, DBS of the STN may again become an effective treatment
option [21]. However, this treatment option does not directly improve dopaminergic-induced FOG,
but only alleviates the problem indirectly by treating the cardinal symptoms of PD, enabling a reduction
in the dopaminergic medication. No large-scale studies on the prevalence of dopaminergic-resistant
FoG were reported, however, Amboni et al. described 36.6% of 325 PwP had FoG in the on-medication
and off-medication states [23]. Treatment options for dopaminergic-resistant FoG are primarily in the
research setting and are not currently implemented in clinical practice. Limited evidence suggests that
Levodopa-carbidopa intestinal gel therapy [25]; transcranial direct current stimulation (tDCS) [26]; and
DBS of the pedunculopontine nucleus (PPN) [27] may become possible treatment options, however,
further research is required if they are to be clinically accepted.
The above-mentioned treatment options for FoG have some limitations: (1) changing
dopaminergic medication to manage dopaminergic-responsive or dopaminergic-induced FoG can
result in dose-limiting side-effects or worsening of the cardinal symptoms. (2) Surgical options
are invasive and costly ($35,000 to $50,000 for DBS (National Parkinson’s Foundation) Current
research-based treatments for dopaminergic-resistant FoG are lacking clinical evidence. Consequently,
there is a need to provide new and improved treatment options for FoG. One such treatment option is
the adoption of cueing techniques.
Cueing is a well-established technique that has been shown to improve gait in PwP including
increasing walking speed, step length, cadence (total number of steps taken per minute) and reducing
the number of FoG episodes [2,28].
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Cueing can be defined as using external stimuli which provides temporal (related to time) or
spatial (related to space) information to facilitate movement (gait) initiation and continuation [29].
The effect of cueing modalities on the specific subtype of FoG (i.e., dopaminergic-responsive,
dopaminergic-induced or dopaminergic-resistant FoG) is poorly reported in literature. This may be due
to the fact that distinguishing the different FoG subtypes requires a comprehensive motor assessment
in at least three medication states [30]. It is more common for the literature to report the effect of cueing
modalities on FoG that occurs while the PwP is in either; (1) the on-medication state (referred to as
On-FoG); (2) the off-medication state (referred to as Off-FoG) or (3) the end-of-dose-medication state
(referred to as EoD-FoG).
Three cueing modalities are extensively reported in literature: visual cueing, auditory cueing and
somatosensory cueing. These modalities reflect the specific external stimuli that the cueing technique
utilizes (i.e., visual cueing provides visual stimuli). A further modality may be considered when
combining two types of cueing modalities (i.e., visual-auditory cueing simultaneously provides both
visual and auditory stimuli).
The precise mechanism(s) underlying the effectiveness of cueing to ameliorate FoG is unclear,
however, previous studies have suggested:
1. Cueing may compensate for the defective internal rhythm generator of the basal ganglia,
consequently affecting the coordination and execution of movement [31,32]. In this way, the PwP
may use auditory, visual or somatosensory cueing to provide temporal information (external
rhythm) to which movement can be coupled [33].
2. Another theory is that the PwP may use visual cueing to provide spatial information to scale
and guide movements, which may allow the PwP to bypass their defective basal ganglia during
gait [34].
3. Previous studies also have suggested that cognitive/attentional mechanisms might explain the
positive effects of cueing on FoG. Namely, auditory, visual or somatosensory cueing may shift the
PwP’s attention to the task of walking, helping them to consciously think of what to do next [35].
4. Studies indicate that enhanced proprioceptive information processing could be the mechanism
underlying the positive effects of cueing on FoG. In this way, the PwP may use visual or
somatosensory cueing as an artificial means to stimulate the proprioceptive inputs, providing
enhanced information on limb position and movement during gait [36].
The use of visual cueing to ameliorate FoG was reported as early as 1990 [37]. Dietz et al.
demonstrated that walking over parallel lines marked on a floor (visual stimuli) could reduce the
occurrence of FoG. Parallel lines can provide a simple method of conveying spatial information, such as
step length, through the spacing of each line (Figure 1a). For instance, Dietz et al. spaced parallel
lines every 305 mm and instructed the PwP to step over each line as they walked across the floor,
thus regulating their step length. It is unknown if the action of regulating the PwP’s step length directly
results in a reduction in the number/duration of FoG episodes or if the simple method of drawing
attention to the stepping process (i.e., thinking about stepping over the lines) was the contributing
factor. Or indeed, if visually focusing on the lower limbs during the stepping process (providing
enhanced proprioceptive information) was a contributing factor.
Auditory cueing was reported to ameliorate FoG in a study by Enzensberger and colleagues in
1997 [38]. In this paper, Enzensberger proposed the use of a metronome to investigate its effect on FoG.
Metronomes are devices that provide a regular, repeated audible sound (i.e., tick, beat and click) at an
interval that can be adjusted, typically in beats per minute (bpm). They provide a simple method of
conveying temporal information, such as step duration, through the rhythmical timing of each beat
(Figure 1b). For instance, Enzensberger et al. set the rhythm of the metronome to 95 beats/minute and
instructed the PwP to step in time to the beat of the metronome, therefore modifying and regulating
the PwP’s step duration to 0.63 s. In addition, Enzensberger et al. also proposed the use of shoulder
tapping (somatosensory stimuli) to investigate its effect on FoG [38]. Shoulder tapping can convey
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temporal information, such as step timing, through rhythmically tapping on the PwP’s shoulder
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i r . Thr e cueing modalities to ameliorate FoG. (a) Visual cueing: parallel lines marked on
the ground at a fixed dist nce apart, conveys spatial information, such as step length; (b) Auditory
cueing: a metron me prod cing auditory stimuli at a set beat, conveys temporal information, such as
step duration; (c) Somatosensory cueing: Tapping of a people with Parkinson’s (PwP) shoulder at
a set rhythm, also conveys temporal information, such as step duration. Both spatial and te poral
infor ation ay be perceived by P P and processed through ultiple brain regions (B basal
ganglia, S A supple entary otor area and cerebellu ) to a eliorate FoG and i prove gait.
Initial reviews by Lim et al. in 2005 and Nieuwboer et al. in 2008 on cueing, suggested insufficient
evidence for the effectiveness of cueing to ameliorate FoG [2,35]. However, only six studies in total
were included in the reviews [29,37–41], possibly reflecting the limited number of published studies
investigating cueing as a method to ameliorate FoG prior to 2008.
Over the last decade, a significant number of studies, investigating the effect of cueing on FoG,
have been published. These studies can be grouped into two categories.
•
use, with the objective of the cu ing being to provide an immediate b nefit in terms a reduction
in the number/duration of FoG episodes.
• ti cueing: a number of studies have investigated the therapeutic eff ct of cueing [60–7 ].
During these studies, the Pw enga ed in a number of therapy ses ions per e
i . i i i l li i i .
i i i i fi , i li
l i i t it it t c ei ei rovided.
These different approaches to ameliorate FoG have provided various technical challenges
that led to the development of novel cueing systems. Examples of these cueing systems are
custom-built metronomes [44], laser light canes [42], optical head-mounted displays [56], custom-built
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vibratory units [36] and electrical stimulation systems [54]. The effectiveness of these systems to
ameliorate FoG has been suggested to be strongly dependent on the cueing modality adopted
and the specific information that the cue provides [35]. Additionally, a key challenge identified
by Lim et al. [2] is whether positive laboratory-based results translate into similar performance in
daily living environments. Therefore, to enhance our understanding of the technical characteristics
of current cueing systems and the effectiveness of these systems, this paper aims to present a
chronological review of the literature relating to the development and performance of cueing systems.
This technological literature review may prove instructive for future researchers looking to enhance




A technological review of the literature on cueing devices addressing FoG in PD was carried out
in an attempt to address the following research question: what is the current state of the art in cueing
systems that have the potential to be used at home as a self-administer intervention for FoG and how
effective are they?
2.2. Article Search Strategy
Article selection was based on a search for publications following the PRISMA guidelines [71] of
the following scientific databases: IEEE Xplore, Embase, PubMed, Science Direct, Scopus, and Web
of Science. All publications from January 2009 to December 2018 were included in the search.
The electronic databases were searched by the first author (D.S.) for relevant articles using the following
search terms mentioned in the title or abstract or keywords: “Parkinson” AND (“cue” OR “cues” OR
“cueing” OR “freezing”).
In addition to the search terms, the following search filters were applied: (i) full journal article;
(ii) written in English; (iii) appeared in a peer-reviewed academic source. To identify additional articles,
a snowball technique was used through additional hand-searching of references and citation tracking
from relevant articles.
2.3. Article Screening
Articles were initially screened by the first author (D.S.) based on title and abstract. Articles
were excluded from the systematic review if they fulfilled any of the following criteria: (i) did not
present a wearable cueing system to address FoG in PD; (ii) systems could not be used for take-home
applications (ii) present insufficient technical detail on the cueing system (iii) not full journal article
or reported on previous published work and (iv) written in any language other than English. Where
the title or abstract did not provide sufficient detail to determine exclusion, full-text articles were
reviewed. Based on the above criteria, full-text revisions were performed by the first author (D.S.) and
then assessed independently for eligibility by the second authors (G.OL. and L.R.Q.).
2.4. Quality Assessment
The studies included in this review primarily used single-case design approaches. These types
of studies involve within-subject repeated measures and can provide a viable alternative to large
group studies. Quality assessment tools for single-case studies are relatively new, with no currently
accepted “gold standard” tool [72]. However, a well-established tool that has been recommended for
use in systematic reviews of single-case studies, is the “What Works Clearinghouse (WWC)” tool [73].
This tool assesses the validity of single-case studies, classifying them as either “Meeting Standards,”
“Meeting Standards with Reservations,” or “Not Meeting Standards” [74]. As described in the WWC
guidelines, studies were required to describe the systematic manipulation of the independent variable
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with the researcher actively determining when and how experimental conditions were changed. Upon
successful demonstration of control of the independent variable by the researcher, studies were then
further assessed as follows:
• Each outcome variable was systematically measured and an inter-observer agreement (IOA) was
reported for a minimum of 20% of data for each experimental condition. The IOA score must
meet or exceeded 80%.
• The study included at least three replication attempts of intervention effects at different points in
time or in three different phase repetitions.
• An intervention phase met the minimal data point threshold for the design type as specified by
WWC guidelines [74].
3. Results
The outcome of the systematic search is summarized in Figure 2. The initial search identified
4480 records. Reference manager software EndNote X5 (Thomson Reuters, Philadelphia, PA, USA)
was used to collate results. Duplicates were removed and a screening process of both the title and
abstract of the remaining records was subsequently conducted. The full-text of the remaining records
were then assessed for relevance to the review. Following this procedure, 18 articles remained for the
systematic review.
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Figure 2. PRISMA flow diagram of study selection.
3.1. Auditory Cueing Devices
In 2010, Bachlin a d colleagues identifie li tions with metronome cueing d vices, such as
those previously reported by Enzensberger et al. and Cubo et al. [38,39]. When activated, these devices
continually delivered auditory cueing regardless of whether FoG was present or not. This design
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limitation was identified by Cubo et al. who commented on the possible problem of continuous
auditory cueing, reporting that PwP may become habituated to the auditory stimuli, thus reducing the
effect of cueing [39]. To address this limitation, Bachlin and colleagues presented an auditory cueing
system that provided auditory cueing only during an actual FoG episode [75,76]. In comparison to
a continuous cueing system, which aims to prevent FoG from occurring through continues cueing,
Bachlin’s system provided On-demand cueing which proposed to relieve FoG once it happened.
The system was implemented using a wearable research platform designed for rapid prototyping
(Figure 3). The platform provided a custom wearable computer that interfaced to sensors and the
user. On a 3.3 Ah battery, the wearable computer ran for more than 6 h. In its then configuration,
wired headphones were placed around the user’s neck and connected to a small wearable computing
(132 × 82 × 30 mm3 and 231 g) worn on the waist. An acceleration sensor (22× 41× 12 mm3 and >22 g)
was attached to the shank (just above the ankle) of the user and transmitted data to the small wearable
computer over a Bluetooth classic communication link. Seminal work carried out by Hausdorff et al. [7];
and Moore et al. [77]; into the principles of FoG detection algorithms enabled Bachlin and colleagues
to develop a FoG detection algorithm for real-time operation. The algorithm was implemented with a
lag time (time between the occurrence of a FoG episode and its detection) of less than 2 s. The main
computational part of the algorithm used an fast Fourier transform (FFT) calculation to determine the
power content of the acceleration sensor data between 0.5 and 3 Hz (walking band) and 3 and 8 Hz
(freeze band), as suggested by Moore et al. [77]. A method of thresholding was used to determine if
the user was in a standing, walking or FoG state. By implementing their algorithm within the Linux
operating system of the small wearable computer, the system would produce a rhythmic ticking sound
at a tempo of 60 beats/minute whenever a FoG episode was identified, and this lasted until the user
resumed walking. For all users, this provided a cue every one second, during the period the user was
in FoG. Bachlin et al. did not explain why they choose to use auditory cueing with a fixed tempo of 60
beats/minute. Interestingly, the normal cadence for men and women aged 65–80 years was reported
as, 81–25 steps/minute and 96–136 steps/minute respectively [78]. This was significantly higher than
the 60 beats/minute produced by the auditory cueing system.
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the  technical  effectiveness  of  their  system  and  to  collect  feedback  about  the  system.  During 
laboratory‐based waking  tasks  both  the  accuracy  of  the  online FoG detection  algorithm  and  the 
Figure 3. Illustration of user wearing the On-demand auditory cueing system, presented by Bachlin et
al. A wired headphone was worn around the neck of the user and connected to a wearable computer
that was attached to the lower back. An acceleration sensor was attached to the shin and connected to
the wearable computer over a Bluetooth classic communication link.
In a repeated measures proof of concept study, Bachlin and colleagues carried out measurements
on 10 participants (eight in the On-medicated state and two in the Off-medicated state) to
understand the technical effectiveness of their system and to collect feedback about the system.
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During laboratory-based waking tasks both the accuracy of the online FoG detection algorithm and
the effectiveness of the system at reducing the frequency and duration of FoG episodes was evaluated.
Using a subjective questionnaire, Bachlin et al. presented data on the experience of eight participants
(two of the 10 participants did not experience FoG during walking tasks). Three participants expressed
no change in frequency of FoG episodes and five expressed a lower frequency of FoG episodes with
the cueing system compared to without the system. In addition, two participants expressed no change
in the duration of FoG episodes; five expressed shorter FoG episodes and one expressed longer FoG
episodes with the system compared to without the system. However, no statistical data was presented
on the frequency or duration of FoG episodes during the walking tasks. Therefore, no statistical
conclusion could be made on the systems effectiveness in ameliorating FoG. Furthermore, Bachlin
and colleagues acknowledged the short time available for the participants to test the system (<1 h)
and were only in a position to speculate on what might be the benefit of the system over a longer
duration. A drawback of the system was the varied level of sensitivity and specificity of the online
FoG detection algorithm among participants, with average values of 73.1% and 81.6%, respectively.
For some participants, the low specificity value resulted in the participants requesting to hear the
auditory cueing less and for some participants, the low sensitivity value resulted in the participants
requesting to hear the auditory cueing more often.
This was reported by Bachlin et al. to affect the overall acceptance of the system. Although
Bachlin et al. showed that a user-specific optimization of the FoG detection algorithm could improve
sensitivity and specificity to 88.6% and 92.4%, this was demonstrated during offline post-processing.
It is worth noting that, although the system was bulky, only one participant commented that
it should be miniaturized. Participants also commented negatively on the use of the headphones
around the neck, reporting “that people in the surroundings should not notice they are wearing such a
system, either by seeing it or by hearing the ticking sound”. One participant suggested introducing
variations in the audio tone and rhythm to avoid becoming used to the system. Bachlin et al. also
presented data on the feedback of four physiotherapists on the system. Two physiotherapists saw
potential in the system to support PD participants in their everyday life, although, two thought it less
suitable, especially due to the size and the attachment method to the belt. However, the physiotherapist
did not see any indication that the size of the system disrupted the participant’s normal gait. One
physiotherapist suggested adjusting the tempo of the auditory cueing according to the cadence of the
participant. This was an important comment, as previous work had identified that when different
tempi were utilized, auditory cueing changed some of the altered walking parameters (stride length,
cadence and gait velocity) in PwP [79].
Interestingly, Bachlin et al. also investigated multiple on-body locations for the optimal location
of the acceleration sensor during the trial; shank (just above the ankle), and thigh (just above the
knee of the same leg) and the trunk of the participant. Offline comparative analysis of these on-body
sensor locations showed little difference in the accuracy of the FoG detection algorithm, indicating
that an acceleration sensor may be placed at multiple locations without losing significant accuracy.
However, Bachlin et al. reported that the best result was achieved when using the vertical axis of the
acceleration sensor located at the knee and the worst was achieved when using the vertical axis of
the acceleration sensor located at the hip. Bachlin et al. commented that performance may be further
enhanced by using multiple sensors, especially for users that do not exhibit trembling of both legs
during FoG. In conclusion, Bachlin et al. acknowledged there were further possibilities for technical
improvements. These improvements included; (1) the integration and miniaturization of the system
into a single sensor node and (2) adjustment of the auditory cueing tempo using sensor recordings of
the user’s natural cadence.
In the same year, Arias and Cudeiro presented a custom-built portable device that provided
auditory cueing via a set of headphones [44]. In this paper, Arias hypothesized that auditory cueing
delivered at a tempo scaled to the user’s cadence (10% above the normal cadence of the user), would
modify their walking pattern and help to alleviate EoD-FoG. To investigate the hypothesis Arias et al.
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developed an auditory cueing device that provided a rhythmic 4625 Hz auditory tone, delivered
in bursts of 50 ms duration with an adjustable tempo. The functionality of the system lacked the
sophistication of Bachlin’s system, by comparison, did not provide auditory cueing when required but
instead provided continuous auditory cueing at a tempo scaled to the user’s cadence. Implementing
an adjustable tempo was an important feature of Arias and Cudeiro device, as the ideal cueing tempo
to improve gait in PD is now receiving widespread attention [50,80]. Within the paper, the authors did
not explain the choice of a 4625 Hz tone, delivered in pulses of 50 ms, but it may reflect that humans
are most sensitive to low-intensity sounds at frequencies between 2000 and 5000 Hz.
To investigate the effect of their system on EoD-FoG, Arias and Cudeiro carried out measurements
on 10 participants as they performed a ~16 m walking task with and without auditory cueing. Video
footage analysis from each waking task was performed by a specialist, who identified the frequency
and duration of FoG episodes. Arias and Cudeiro observed a significate immediate positive effect
of auditory cueing on the mean frequency of EoD-FoG episodes (without cueing: 5.9 ± 6.707; with
cueing: 1.4± 1.265, p = 0.014) and mean duration of EoD-FoG episodes (without cueing: 3.119 ± 4.93 s;
with cueing: 1.02 ± 1.699 s, p = 0.017). However, the study failed to meet WWC single-case design
standards due to a lack of dual assessor’s analyses of outcome measures. Furthermore, Arias and
Cudeiro acknowledged the short time provided to the participants to test the device, and therefore its
efficacy during repeated, daily use is not reported.
Following Arias and Cudeiro’s work, research attention shifted from the development of
custom-built wearable auditory cueing devices to the utilization of technologies available in the
market-place. In 2012 and 2016, Lee et al. and McCandless et al. respectively investigated the effect
of rhythmic auditory cueing on FoG using commercially available electronic metronomes [45,50].
The SDM300 SAMICK Metronome (SAMICK Musical Instruments Co., Ltd., Enmseong County, South
Korea), featured two large tempo and tone control knobs (40–216 beats/minute and 45–440 Hz tone),
a built-in speaker and a headphone jack. The device was comparable in size to Bachlin’s research
platform, but it did not feature a means to attach it to the user (Figure 4).
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Figure 4. Both the SDM300 SAMICK and Peterson BodyBeat Pulsing Metronome provide features such
as tempo, tone and volume adjustments, a built-in speaker and a headphone jack.
While investigating the immediate effect of auditory cueing on Off-FoG, Lee et al. carried
out measurements on 15 participants with FoG as they performed a ~14 m walking task without
auditory cueing, with auditory cueing and with visual floor markers. Based on previous results (which
investigated the effect of tempo on stride length and walking speed of PwP in the On-medicated
state) [81], and unlike Arias and Cudeiro, Lee et al. choose to set the tempo of their device from 10% to
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20% below the normal cadence of the participant. Lee et al. reported a significant immediate negative
effect of auditory cueing on the mean frequency of Off-FoG episodes (with cueing: worsened by
56.7 ± 8.2%, p = 0.024). Although, video footage was analyzed for outcome measures by two assessors,
inter-assessor agreement was not documented using a statistical measure, therefore, this study failed
to meet WWC single-case design standards. It was unclear if headphones or the speaker was used
during the study as Lee et al. did not provide information on the setup of the metronome. Again,
user experience results were not reported, which could have provided insight into the effectiveness of
commercial metronomes, during everyday use, to manage FoG.
The BodyBeat Pulsing Metronome (Peterson Electro-Musical Products, Inc., Alsip, IL, USA),
featured a digital LCD, a keypad control, a built-in speaker and a headphone jack (Figure 4) [45].
The device is smaller in size to the SDM300 metronome and provided a clip for attachment to the user.
The auditory cueing tempo could be adjusted between 10 and 280 beats/minute, and the device could
produce four different metronome rhythmic sounds (Rimshot, Clave, Wood Block and Beep).
To investigate the immediate effect of auditory cueing on Off-FoG, McCandless et al. carried out
measurements on 20 participants as they performed a >3 m walking task with and without auditory
cueing. McCandless et al. set the tempo of their device to either 70, 60 or 50 beats/minute, based on
participant’s preferences.
McCandless et al. reported an immediate positive effect of auditory cueing on the mean
percentage of Off-FoG episodes during the walking task (without cueing: 81.58 ± 7.53%; with cueing:
44.44 ± 7.74%). Inter-assessor agreement was not documented, therefore, this study failed to meet
WWC single-case design standards. As in Lee’s case [50], McCandless did not provide information on
the setup of metronome or user experience results.
In 2014, research attention shifted from laboratory-based evaluations to home-based evaluations,
and with it, the development of auditory cueing devices designed for PwP and take-home applications.
In this year, Samá et al. presented the REMPARK system [82]. The system was developed as a personal
health device for the remote and autonomous management of PD and included an auditory cueing
system developed to improve gait and relief FoG. Although Bachlin et al. previously proposed that
their auditory cueing system could be miniaturized into a single sensor unit that could detect FoG and
transmit a trigger signal to a feedback device [75], Samá et al. were the first to present such a system
(Figure 5). Samá et al. presented a custom-built single sensor unit (77 × 37 × 21 mm3 and 78 g) that
attached to the trunk of a user. The sensor unit implemented frequency analysis and machine learning
approaches to determine the presence of PD symptoms such as bradykinesia, dyskinesia, and FoG.
The main reference for the algorithmic approach is described by Ahlrichs et al. [83]. Upon detection of
a symptom(s), the sensor unit would transmit a trigger signal to the feedback device (smartphone),
which streamed rhythmic auditory cueing to an ear-set until the user resumed walking without FoG
or bradykinesia.
To increase acceptability and reduce possible stigmatization, Samá et al. adopted a smartphone as
the feedback device. This refinement in the design of auditory cueing systems enabled the development
of smartphone application interfaces that were specifically tailored to the needs and abilities of PwP.
In a further follow-on publication, Nunes et al. presented detailed information on the development of
the auditory cueing smartphone application [84]. In summary, the smartphone application allowed
the user to select their preferred auditory cueing settings: turn on/off auditory cueing, change volume,
change the type of auditory stimuli (metronome sounds, musical beats, clapping and verbal cueing)
and adjust the tempo (beats/minute). Another refinement in the design of auditory cueing systems
was the use of a single wireless ear-set. This refinement enabled the users not only to hear the auditory
cueing but also to perceive other auditory stimuli from the surrounding environment.
Unfortunately, Samá et al. did not perform a clinical study to evaluate the effectiveness of the
system to ameliorate FoG. However, Samá et al. reported that the FoG detection algorithm could be
employed with a lag time of roughly 3.2 s (time between the appearance of a FoG episode and its
detection) with a sensitivity of 82.2% and specificity of 92.8%. The long lag time may prove to be a
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drawback of the system as it reduced the applicability of the system to provide auditory cueing for
FoG that persists for less than 3.2 s.
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Figure 5. Illustration of user earing the au itory cueing syste , evelope by Sa a et al. ireless
Sa s g (Sa s g ro . Seoc o istrict, Seo l, So t orea) 3500 ear-set, a se sor it aro
the user’s waist and a smartphone (Samsung Galaxy Nexus) with auditory cueing application was
worn on-body. The smartphone connected to the ear-set and sensor unit over a Bluetooth classic
communication link.
In 2015, Mazilu et al. presented the GaitAssist system, an auditory cueing system developed to
provide motor training and gait assistance at home [85]. The GaitAssist system was similar to the
Samá et al. auditory cueing system. However, Mazilu and colleagues presented further refinements to
the design of an auditory cueing system. In comparison to the Samá et al. auditory cueing system,
Mazilu et al. adopted a smartphone as the feedback device and also utilized the computing capabilities
of a smartphone to perform FoG detection. Mazilu et al. developed a smartphone application that
implemented frequency analysis and machine learning techniques to detect FoG and produce a
rhythmic ticking sound when FoG was identified or anticipated. Based on prior works investigating
the optimal sensor location for the detection of FoG [75,86], Mazilu et al. presented two custom-built
sensor units that attached to each ankle of a user (Figure 6). By streaming movement data from these
sensor units in real-time to the smartphone, Mazilu et al. demonstrated that their FoG detection
algorithm could be employed with a lag time of approximately 0.5 s at a sensitivity of 97.1% and a
false negative rate of 26.5%. The reduced lag time was in part due to employing a processing data
window of 2 s, while Bachlin et al. and Sama et al. used a window of 4 and 3.2 s, respectively.
In addition, the smartphone application could be used to automatically customize the auditory
cueing tempo to the user’s cadence through real-time analyses of gait data. This method was an
innovative step that enabled a fast, robust and straightforward setup of the auditory cueing tempo.
The system performed automatic customization of the auditory cueing tempo by requesting the user to
walk naturally in a straight line, for 30 s, between a “Start” and “End” signal given by the smartphone.
Following the request, the system would analyze the movement data from the two sensor units and
automatically count the number of steps and compute the cadence of the user.
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Figure 6. Illustration of a user wearing the GaitAssit system. Wired earphones were placed in the
user’s ear, two sensor unit are attached to each lower leg and a smartphone (Samsung S3 mini) with
auditory cueing application was worn on-body. The smartphone connected to each sensor unit over a
Bluetooth classic communication link.
In a proof of concept study, Mazilu et al. carried out a three day study on five participants which
assessed the immediate effect of their system on FoG during natural daily life activities. Results
showed a reduction in the tread of FoG frequency and durations for four out of five participants over
the course of the three days. However, the analysis was made on sensing data from five participants,
and therefore no statistical conclusion could be made on the system’s effectiveness in ameliorating
FoG. Interestingly, Mazilu et al. evaluated the performance of the system using the FoG detection
capabilities of the system. The system stored the frequency and duration of FoG episodes detected
during the three days of study. Moreover, as highlighted by Moore et al., wearable sensing data is
considered a valid objective method of assessing FoG [77]. This method of evaluation reduces the
complexity of performing home evaluations, which would require video recordings (for gold-standard
measurements) and provoke privacy issues.
Using a subjective questionnaire, Mazilu et al. also presented data on the experience of nine
participants who used the system for approximately three hours in total over a period of one week.
Mazilu et al. observed one common wearability drawback of the system; participants reported
difficulties in attaching the sensor units, requiring help from another person. Participants also
commented on the use of the earphones, and although, there were no reported issues with plugging
the earphones into the smartphone’s socket, participants preferred not to use them because they could
also hear the auditory stimuli through the mobile phone’s speaker. Overall, participants presented a
positive opinion toward using the system in daily life.
In 2016, following the introduction of smartglasses by Google (Google LLC. Mountain View,
California, USA) and Microsoft (Microsoft Corporation. Redmond, Washington, USA), Zhao et al.
suggested that this new technology may make cueing more accessible to PwP [48]. Smartglasses
share similar features with smartphones (e.g., GPS, WiFi, accelerometers, and audio/visual output),
however, unlike smartphones their displays can be conveniently worn like conventional glasses. To
investigate the feasibility of smartglasses as cueing devices, Zhao et al. proposed to use Google
Glass as a platform to evaluate the effect of continuous auditory cueing on FoG. Zhao and colleagues
developed an Android app for Google Glass that utilized the bone-conduction and voice/gesture
control capabilities of Google Glass (Figure 7). Bone-conduction allowed users to hear the rhythmic
auditory sound through vibrations of Google Glass.
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provided  targets  for  the user  to  step on with  long  strides as  they walk.  In addition  to  the visual 
display, the system also offered auditory feedback from the user’s steps, through earphones. 
Figure 7. Illustration of the continuous auditory cueing system, used by Zhao et al. The Google ‘Glass’
syste provided features such as onocular display and bone-conduction sound. During auditory
cueing the onocular display is clear and the bone-conduction speaker delivers a burst of audio cueing
at a set tempo.
s r it the app through voice/gesture control which allowed the user to adjust the
auditory cueing tempo betw en 50 and 150 beats/minute.
t i t - c rrie t
eas r ts artici ts. uring laboratory-based, 20 and 8 alking tasks, the frequency
a ration f - is es ere l te it it t it r i . In li e it
r i , l. c s t set t e te f t eir e ice t t e r al ca e ce of t e
rtici a ts. Zhao et al. reported no significant changes in t e fre e cy r ti f -
e is hen all walking tasks were considere together. However, Zhao et al. bserved a significant
immediate effect of auditory cueing n the mean frequency o EoD-FOG episodes (p < 0.05) during
walking tasks with 360◦ turning. This study meets WWC single-case design standards, however
due to the small sample size of FoG episodes (six participants experienc d EoD-FoG more than onc ,
four exhibited no EoD-FoG, and two h d a single EoD-FoG episode), the effect of auditory cueing on
EoD-FoG was reported to be inconclusive.
sing a jecti e estionnaire, hao and co leagues presented data on t e rie ce f
rtici a ts er t st it t i . ine articipants ere i ling to se le lass at
o e to a ress . e e artici a ts re rte t e f le lass easy r er eas t se
a i e participants reported the instructions the scre n lear or very clear to read. One participant
rti ul rly liked the bone-conducting headphone because the metronome was less audible to others
around them. Zha et al. acknowledged there were further possibilities for techn cal imp ovements
before Google Glass can be adopted for daily use, which included the ability to detection FoG.
3.2. Visual Cueing Devices
In 2010, Espay et al. highlighted that cueing systems predominantly provided cueing at a set
tempo that was scaled to the user normal cadence [61]. However, preliminary clinical studies indicated
that when the tempo of cueing was not externally set, but, was an outcome of the user’s current
motion (i.e., dynamic), PD gait could be improved [79,87]. To investigate this hypothesis, Espay et al.
developed the Visual-auditory walker, a continuous visual-auditory cueing system for home-based
use by PwP [61]. The system was composed of a sensor unit and a head-mounted micro-display with
earphones (Figure 8). The system simulated optic flow (pattern of apparent motion in a visual field of
view) by displaying a virtual checkerboard-tiled floor superimposed on the real world. The virtual
checkerboard-tiled floor responded dynamically to the user’s motion and moved toward them at a
speed set equal to their gait speed, as measured by the sensor unit. The checkerboard-tiles provided
targets for the user to step on with long strides as they walk. In addition to the visual display, the
system also offered auditory feedback from the user’s steps, through earphones.
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Figure 8. Illustration of the isual-auditory alker, developed by Espay et al. The syste as
co pose of a sensor unit and a head-mounted micro-display with earphones. The sensor unit as
attached to the user’s clothing and the headset worn around the eyes. The s stem provided continuous
optical flow visu l cueing. During cueing, a virtual checkerboard-til d floor is overlayed n top of
the user’s field of view (T1) and continually moves forward on the scree at a rat equal to th user’s
real-time gait speed (T2).
In a f si ility st y, Espay et al. carried t eas re ents on 15 articipants to assess t e ffect
of optical flo vis al c ei r t t t t i . ,
participants were instructed to use the visual cueing system while walking for no less than one hour a
day. Before and after the treatment period, a FoG questionnaire (FOGQ) [88] was used to evaluate the
eff ct of visual cueing on FoG. The FOGQ is a validated clinical tool that uses a six-item questionnaire
to assess the severity of FoG in veryday life subj ctively. The qu s onnaire scor the severity of FoG
from 0 to 24, with the higher scores corresponding to more severe FoG.
ver the two we ks treatment period, Espay et al. observed a positive effect of visual cueing o the
mean FOGQ score (pre-treatment: 14.2 ± 1 9; post-treatment: 12.4 ± 5, p = 0.002). In addition, a trend
towards an improvement in th frequency of FoG was reported (pre-treatment: 2.92 episodes/day;
post-treatment: 2.54 episodes/day, p = 0.09). However, Espay et al. reported that tw participants
did not feel comfor able using the headset (because they were “clunky” or “embarrassing to u e in
public”) and d d not train at home as instructed. I teres ingly, Espay et al. did not directly m nitor the
usage f the system at home. Although, they did req est verbally confirmation of compliance, it could
be conclud d hat the independent variable (intervention) w s inadequately controlled, meaning he
study would fail to meet WWC single-case design standard . Int restingly, participants were instructed
to use both visual cueing an auditory feedback. Espay et al. reported that personal preference force
some to rely on only on or none. Four participants favor d the combination of visual cueing and
auditory feedback; three participants preferred just auditory feedback, hree visual c eing alone,
and two neither.
In the sa e year, Bryant and col eagues presente a alking cane device that projecte a
co ti i an a tached laser [43]. As the user walked wi the walking cane,
the laser co tin ously projected a s atic horizontal laser line onto the ground at t l i g
cane. fl
lthough walking canes with attached lasers wer available com ercially to PwP in 2010, Bryant et al.
identified that these devices only projected a red laser line a d there was no current evid nce on the
benefit o different laser line colors on FoG. Ther fore, to investigate the effect of laser line l ,
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Bryant and colleagues presented a walking cane device that projected either a red or a green laser line
through an attached commonly available laser pointer.
In a pilot study, Bryant et al. carried out measurements on seven participants (all participants
usually used walking aids to ambulate) during two different laboratory-based waking tasks (15.2 m
straight walking task with a 180◦ turn and a 360◦ turning task) and evaluated the frequency of Off-FoG
and On-FoG episodes during each task. For each walking task, participants used the walking cane
while it either projected a red laser line, a green laser line or no laser line.
Bryant et al. reported a significant positive immediate effect of a green laser line on both the
mean frequency of Off-FoG episodes during the 15.2 m walking task (without laser line: 0.67 ± 0.52;
with green laser line: 0.0 ± 0.0, p < 0.05) and 360◦ turning task (without laser line: 2.14 ± 1.35; with
green laser line: 0.29 ± 0.49, p < 0.05). The effect of a red laser line was negative during the 15.2 m
walking task (without laser line: 0.67 ± 0.52; with red laser line: 0.83 ± 0.75, p > 0.05) and positive
during the 360◦ turning task (without laser line: 2.14 ± 1.35; with red laser line: 1.43 ± 0.98, p > 0.05).
When the participants were tested in the On-medicated state, Bryant et al. also reported an immediate
positive effect of a green and red laser line on the mean frequency of On-FoG episodes during the
15.2 m walking task (without laser line: 0.29 ± 0.49; with green laser line: 0.0 ± 0.0; with red laser
line: 0.14 ± 0.38, p > 0.05) and 360◦ turning task (without laser line: 1.0 ± 1.0; with green laser line:
0.57 ± 0.79; with red laser line: 0.57 ± 0.79, p > 0.05). However, due to the small sample size of
participants (seven), the generalizability of the results was limited. In addition, it was not reported if
analysis of the outcome measures was performed by two assessors, therefore, this study failed to meet
WWC single-case design standards.
Bryant et al. suggested that the more positive effect of the green laser line on the frequency of FoG
episodes may be due to two factors. Firstly, the general perception that a green light means “go” and a
red light mean “stop” as indicated by traffic signals. Secondly, under lighting conditions, the human
eye is most sensitive at a wavelength of 555 nm. Therefore, the green color line appeared brighter
(approximate wavelength of 532 nm) than the red line (approximate wavelength of 650 nm) during the
walking tasks. Using a subjective questionnaire, Bryant et al. also presented data on the participants’
perception of the effectiveness of two laser line colors and observed that most participants believed the
green line helped the most during both walking tasks.
In 2011, Donovan et al. described a home-based evaluation of the commercially available U-Step
(U-Step Mobility Products, Inc; Skokie, Illinois, USA) walking cane and U-Step walking stabilizer
with an attached red laser (Figure 9) [57]. Although these devices were developed outside this review
period (2006), Donovan et al. was the first to publish an evaluation of the devices. In contrast to the
walking cane presented by Bryant et al., the U-Step walking cane included a weight activated switch
that triggered the projection of a static red laser line only when the user placed a downward force on
the cane. The U-Step walking stabilizer was a four-wheeled rolling walker with a red laser attached
at ankle level. A switch located on the handlebar of the walking stabilizer switched on and off the
projection of a static red laser line onto the ground in front of the user.
In an open-label study, Donovan et al. carried out measurements on 26 participants to assess
the effect of continuous visual cueing on FoG and the sustainability of the effect over time. During
the reported study, participants who normally used a walking cane at home to ambulate received the
U-Step walking cane (n = 16), participants who normally used a wheeled walker to ambulate received
the U-Step walking stabilizer (n = 5) and participants who normally used both to ambulate received
both the U-Step walking cane and walking stabilizer (n = 5). During a baseline assessment period
(without the red laser attachment) participants used their walking aids during ambulation for one to
two months. Following this period, the U-Step waking cane and the walking stabilizer had the red
laser attached. Participants continued to use the devices over a one-month treatment duration. During
the treatment period, a FoG questionnaire (FOGQ) was used to evaluate the effect of visual cueing on
FoG. Donovan et al. suggested that the FOGQ may be a more relevant outcome measure compared to
an assessment of FoG in a doctor’s office. However, it is important to consider that this questionnaire
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relies on the accuracy of the participant’s ability to recall their FoG severity. Due to an expectation of
the treatment benefit the results may have been biased (recall bias).
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Figure 9. Illustration of the U-Step walking cane. The walking cane device projected a red laser line on
the ground only when pressure was applied to the weight activation switch.
Over the four weeks treatment period, Donovan et al. observed a significant effect of visual
cueing on the mean FOGQ score. The mean reduction in the FOGQ score per-week was: week one:
1.51 ± 0.68 (p = 0.036); week two: 1.15 ± 0.67 (p = 0.099); week three: 1.73 ± 0.65 (p = 0.013); and week
four: 0.53 ± 0.43 (p = 0.263). Although Donovan et al. identified a trend towards improvement at
the end of each of the four weeks, they acknowledged the short duration participants had to use the
devices, and therefore their effectiveness during longer periods of use is unknown.
Following Donovan et al. subjective evaluation of the U-Step walking cane and stabilizer,
the systems would be objectively evaluated by Bunting-Perry et al. in 2013 [49] and McCandless et al.
in 2016 [45]. In a pilot study, Bunting-Perry et al. carried out measurements on 17 participants as they
performed laboratory-based walking tasks with and without the projected laser line. In contrast to the
previous visual cueing system modalities the walking stabilizer offered On-demand cueing. In this
mode of cueing the participant pressed the on/off button during FoG episodes to initiate the laser line
and then re-pressed the on/off switch to turn laser off after the FoG episode was aborted.
Bunting-Perry et al. reported an immediate negative effect of visual cueing on the mean frequency
of On-FoG episodes during walking task with gait imitation, straight walking, approaching destination
and turning FoG triggers (without cueing: 0.94 ± 1.9; with cueing: 1.2 ± 2.3, p = 0.84) and walking task
with gait imitation, straight walking, approaching destination, turning and passing through doorway
FoG triggers (without cueing: 6.2 ± 4.8; with cueing: 7.8 ± 7.8, p = 0.58). However, an immediate
positive effect was reported during walking tasks with gait imitation, straight walking and approaching
destination FoG triggers (without cueing: 2.1 ± 3.6; with cueing: 1.8 ± 3.3, p = 0.58). It was suggested
by Bunting-Perry et al. that the concurrent use of the walking stabilizer and the self-activation of
the laser represents a dual-task that may have reduced the effect of visual cueing. Additionally,
Bunting-Perry et al. also suggested that the small sample size of participants and the lack of On-FoG
in a quarter of the cohort may have contributed to the null results observed. Although, video footage
was analyzed for outcome measures by multiple assessors, inter-assessor agreement was not reported,
therefore, this study failed to meet WWC single-case design standards.
In conclusion, Bunting-Perry et al. acknowledged the many pitfalls that exist when studying FoG
and provided instructions for future researchers. These included; (1) minimizing dual tasking by using
continuous visual cueing; (2) ensuring adequate training with visual cueing devices; (3) test various
lasers colors and (4) collect data regarding other features of the participants’ disease, with the goal of
characterizing any subgroup that may respond.
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To investigate the immediate effect of U-Step walking cane on Off-FoG, McCandless et al. carried
out measurements on 20 participants as they performed >3 m laboratory-based walking task with the
projected laser line, without the projected laser line, and without the walking cane. McCandless et al.
reported an immediate positive effect of visual cueing on the mean percentage of Off-FoG episodes
during the walking (without cueing: 40.00 ± 7.85%; with cueing: 27.50 ± 7.34% and without walking
cane: 81.58 ± 7.53%). Interestingly, the walking cane without cueing activated showed an immediate
improvement compared to no walking cane (baseline), suggesting that a walking cane alone may have
a beneficial effect on overcoming FoG. However, as walking tasks only involved two FoG provoking
elements, the generalizability of the results during daily activities is limited. Inter-assessor agreement
was not documented, therefore, this study failed to meet WWC single-case design standards.
In 2012, Buated et al. presented the LaserCane device that was developed at the Chulalongkorn
Center of Excellence for PD and Related Disorders (CCEPDRD) in Thailand (Figure 10) [42].
The LaserCane was similar to the U-Step walking cane and projected static green laser line when the
walking cane was pressed down on the ground. With full battery power the cane provided a laser
beam of 3 mm in width and 750 mm in length. To investigate the immediate effect of continuous
visual cueing on Off-FoG and On-FoG, Buated et al. carried out measurements on 30 participants as
they performed a laboratory-based 5 m walking task. During the walking task, participants used the
LaserCane while it either projected or did not project a green laser line.
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Buated et al. reported an immediate effect of visual cueing on the mean frequency of On-FoG
episodes (without cueing: 0.33 ± 0.84; with cueing: 0, p < 0.05) and Off-FoG (without cueing:
4.20 ± 6.38; with cueing: 0.76 ± 1.85, p < 0.05). Buated et al. also reported that visual cueing was able
to reduce FoG in PwP, with greater impact observed among PwP in the moderate Hoehn and Yahr
stage (Hoehn and Yahr stage is a commonly used system for describing the progress of PD symptoms)
compared to the mild Hoehn and Yahr stage. However, it was not reported if analysis of outcome
measures was performed by two assessors, therefore, this study failed to eet WWC single-case
design standards.
In 2016, research attention shifted fro the integration of visual cueing devices and walking
aid devices (walking canes and wheeled walkers), to the development of visual cueing systems that
were more wearable and accessible to PwP who do not require the use of walking aids. In this year
Zhao et al. proposed to use Google Glass as a platform to evaluate the effect of visual cueing on
FoG [48].
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Zhao and colleagues developed an android application for Google Glass that provided either
optic flow or rhythmic visual cueing. Vertically oriented lines on both sides of the Google Glass screen
that continually moved forward at a steady rate (ranging from 50 to 150 lines/minute) provided optic
flow visual cueing. This type of visual cueing simulated optic flow (pattern of apparent motion in a
visual scene) (Figure 11). In contrast, rhythmic visual cueing was provided by rhythmically flashing
on and off the Google Glass screen at a preferred steady rate (ranging from 50 to 150 flashes/minute),
as illustrated in Figure 11. Although both types of visual cueing have previously been implemented in
prototype devices to improve PD gait [29,89], Zhao et al. suggested that implementing them within
the Google Glass platform may make visual cueing more accessible for a wider audience. The system
allowed the user to interface with the app through voice/gesture control, enabling the adjustment of
the optic flow and rhythmic rate by the user.
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igure 11. Illustration of user wearing google glass and their field of vision during continuous visual
ueing. The Google ‘Glass’ system provid s two mode of continuou visual cueing. Duri g optical
flow mode, a virtual vertically oriented line continually moves forward on the left and then the right
side of the screen at a steady rate (T1–T4). During rhythmic mode, the display flashes on and off a
transparent red screen at a set rate (T1–T2).
To investigate the immediate effect of visual cueing on EoD-FoG, Zhao et al. carried out
measurements on 12 participants in a laboratory setting. During three 20 m waking tasks and a
single ~8 m walking, the frequency and duration of EoD-FoG episodes were evaluated with optic
flow visual cueing, with rhythmic visual cueing, and without visual cueing. With all walking tasks
considered together, Zhao et al. reported no significant changes in the frequency and duration of
EoD-FoG episodes. Although, this study meets WWC single-case design standards, due to the small
sample size of FoG episodes (six participants experienced EoD-FoG more than once, four exhibited
no EoD-FoG, and two had a single EoD-FoG episode), the effect of visual cueing on EoD-FoG was
reported to be inconclusive.
Additionally, Zhao et al. suggest that concentrating on the display while walking potentially
created a visual dual-task, which may have reduced the effectiveness of visual cueing. In addition,
optic flow visual cueing produced by the system was in constant motion at a fixed rate, independent
of the user’s motion. As previously reported, this type of system may have adverse effects on PwP
such as dizziness, loss of balance, and even FoG [87].
Using a subjective questionnaire, Zhao and colleagues presented data on the experience of
participants who were tested with the device. Four participants found it difficult to synchronize to
the continuous visual cueing. They described the continuous visual cueing as annoying, distracting,
demanding too much concentration, and hard to see. Conversely, some participants disliked Google
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Glass’ placement of the visual display in the upper right corner and suggested that images be projected
binocularly or more focally in the visual field. Before Google Glass could be adopted for daily use,
Zhao et al. acknowledged that there were further possibilities for technical improvements. These
included the placement of the display binocularly or towards the center of the visual field to optimize
the effects of visual cueing.
In 2017, Tang et al. presented a custom-built wearable device that provided visual cueing via
a chest-worn laser that continuously projected either a static or rhythmic horizontal laser line onto
the ground one step length in front of the user’s feet [55]. The device was attached over the user’s
chest correspond to the sternum with an elastic bandage. In this paper, Tang et al. hypothesized that
continuous visual cueing delivered rhythmically compensated for the deficiency of previous reported
static visual cueing devices. Flashing on and off the projected laser line at a preferred tempo provided
rhythmic visual cueing.
In an experimental study, Tang et al. carried out measurements on 23 participants. During an
“8-shaped” laboratory-based waking task, the frequency of On-FoG was evaluated with static visual
cueing, with rhythmic visual cueing, and without visual cueing. Tang et al. reported a significant
immediate positive effect of rhythmic visual cueing on the frequency of On-FoG episodes (without
cueing: 66; with cueing: 23, p = 0.001) and immediate positive effect of static visual cueing on the
frequency of On-FoG episodes (without cueing: 66; with cueing: 44, p = 0.742). Although positive
results were shown, Tang et al. acknowledged the limited number of participants tested limited the
generalizability of the results. In addition, analysis of outcome measures was reported to be performed
by multiple assessors, however, inter-assessor agreement was not reported. Therefore, this study failed
to meet WWC single-case design standards.
Shortly after the Tang et al. publication, Ahn et al. presented the Smart Gait-Aid system
(Figure 12) [56]. In contrast to the Zhao et al. Google Glass system, Ahn et al. used the Epson’s
(Seiko Epson Corporation. Suwa, Nagano, Japan) Moverio BT-200 smart glasses as a platform to
evaluate the effect of On-demand visual cueing on FoG. The BT-200 shared similar features with
Google Glass (e.g., accelerometer and gyroscope). However, the BT-200 featured a binocular display
that projected images towards the center of the visual field. This feature was important, as Zhao et al.
had previously identified limitations of Google Glass’s monocular display [48]. In an innovative
step, Ahn and colleagues developed an Android app for the BT-200 that implemented real-time FoG
detection and produced visual cueing that adapted to the user’s gait speed and orientation of their
head. The adaption of the visual cue to how fast the user walks and their current head direction
implied a dynamic system. This was in contrast to the Zhao et al. proposed Google glass system,
which provided visual cueing at a rate equal to the user’s average cadence and was not affected by the
participant’s current gait speed.
Based on work carried out by Coste et al. [90], who developed a FoG detected algorithm using
stride length and cadence, Ahn et al. presented a new a real-time FoG detection algorithm tailored
for smart glasses, called ‘FoG Detection On Glasses’ (FOGDOG). By implementing FOGDOG in the
Android app, the BT-200 displayed blue lines onto the smart glasses binocular display whenever a FoG
episode was identified. The displayed blue lines remained on screen until the user turned them off by
touching the BT-200 controller pad. The projected blue lines (0.5 × 0.1 m2) give an effect of parallel
lines regularly placed on the floor and moved in position based on the downward gaze angle and
gait speed of the user. Thus, giving the effect that the lines approached the user while walking. Ahn
et al. suggested that such adaptive projection of the projected blue lines on the glasses was critical
to maximizing the effectiveness of the system. In a proof of concept study, Ahn et al. carried out
measurements on 10 participants to understand the technical effectiveness of their system. While
wearing the Smart Gait-Aid system, the duration of FoG episodes was evaluated during five Timed-Up
and Go (TUG) tests [91].
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Figure 12. Visual stimuli system presented by Ahn et al. The system consisted of the Moverio BT-200
smart glasses (headset, a control unit and cables) and an android application that displayed parallel
blue lines when FoG was detected (T2–T3). As illustrated, these lines move forward in sync to the
user’s gai speed and head orientation. For example, as th r lowers their head (to look down) he
distance betwe n the lines increases.
By comparing the performance of the FOGDOG to video recordings, Ahn et al. report that
their FoG detection algorithm could be employed with a lag time of roughly 1.1 s (time between the
appearance of a FoG episode and its detection) at a sensitivity of 97% and specificity of 88%. Ahn et al.
reported some limitations of the system, which included the limited computing capability of the smart
glasses and battery capacity. To minimize power consumption, Ahn et al. designed the system such
that it was automatically activated upon detection of FoG episodes or manually activated by the user
depending on the need. However, in spite of such an effort, Ahn et al. observed that the battery
capacity was not enough to use the system all day long without recharging the battery. Although
Ahn et al. did not report user experience of the system, several participants refused to take part in
their experiments due in part to technophobia and that they were doubtful about the effectiveness of
visual cueing. In conclusion, Ahn et al. acknowledged there were further possibilities for technical
improvements, such as developing a cloud-based solution to offload the image processing task of
smart glasses.
Furthermore, in 2017, Barthel et al. identified limitations with previous wearable visual cueing
devices, which included a lack of ease of application during daily life [51]. Barthel and colleagues
reported that the use of smart glasses in daily life poses great challenges on the users’ compliance
in wearing such “cumbersome” devices. In an aim to provide a practically acceptable visual cueing
device for domestic use, Barthel et al. presented the Laser shoes. The Laser shoes incorporated two
laser attachments that were attached to a pair of normal shoes and two heel switches that were placed
under each sole of the user’s foot (Figure 13). During gait, each Laser shoe attachment projected a
static horizontal red laser line orthogonally in front of the opposite foot during heel strike of said foot.
The laser line would remain until the user raises their heel. This cycle repeats itself step after step,
delivering visual cueing alternately to each foot.
To investigate the immediate effect of continuous visual cueing on On-FoG and Off-FoG episodes,
Barthel et al. carried out measurements on 19 participants as they performed laboratory-based walking
tasks with and without visual cueing. Barthel et al. reported a significant immediate positive effect
of visual cueing on the percentage of time in Off-FoG (without cueing: 19.6 ± 5.2%; with cueing:
12.9 ± 5.0%, p = 0.004) and in On-FoG (without cueing: 8.8 ± 4.1%; with cueing: 6.0 ± 3.1, p = 0.004).
In addition, Barthel al. also reported a significant immediate positive effect of visual cueing on the
frequency of Off-FoG episodes (without cueing: 6.0± 1.3; with cueing: 3.3± 1.0, p = 0.007) and On-FoG
episodes (without cueing: 3.3 ± 1.0; with cueing: 2.0 ± 0.9, p = 0.028). However, it was reported that
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video analysis of outcome measures was performed by only one assessor, therefore, this study failed to
meet WWC single-case design standards.
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i ure 13. Illustration of the Laser Shoes, d veloped by Barthel et al. Each laser attachment projected a
red laser line in front of the opposite f ot when ressure was applied to the heel switch within e s o .
Using a subjective questionnaire, Barthel et al. presented data on the experience of the participants
who were tested with and without the system. When asked about the efficacy of laser shoes, 12 out
of 19 participants reported a moderate to large improvement, four a small improve ent, and three
no effect. No participants reported a negative impression. Furthermore, 12 out of 19 participants
expressed interest in acquiring laser shoes, six were unsure, and one not interested.
3.3. Somatosensory Stimuli Devices
In 2016, McCandless et al. purposed the use of the commercially available BodyBeat Pulsing
device to investigate the immediate effect of somatosensory cueing on FoG (Figure 14) [45].
The device provided rhythmic tactile stimulation (pulsed vibration) at an adjustable tempo of 10
to 280 beats/minute via an attachable vibration clip. McCandless et al. purposed to attach the
vibration clip anteriorly over the right side of the user’s pelvis, so it could be felt easily by the user.
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hamstring  or  quadriceps  muscle  of  the  body  side  most  affected  by  PD  (Figure  15).  In  its  then 
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Figure 14. Illustration of a participant weari g the BodyBeat Pulsing Metronome. The metrono was
clipped to a belt t the back of the participant and the vibration lip was placed anteriorly over the
right si e of the pelvis.
To investigate the immediate effect of somatosensory cueing on Off-FoG, McCandless et al.
carried out measurements on 20 participants as they performed >3 m walking task with and
without somatosensory cueing. McCandless et al. set the tempo of their device to either 70, 60 or
50 beats/minute, based on participant’s preferences. McCandless et al. reported an immediate positive
effect of somatosensory cueing on the mean percentage of Off-FoG episodes during the walking task
(without cueing: 81.58 ± 7.53%; with cueing: 68.29 ± 7.25%). However, as walking tasks only featured
two FoG provoking elements, the generalizability of the results to daily activities is limited. Although,
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two experienced neuro-physiotherapists analyzed measurement outcomes, inter-assessor agreement
was not documented, therefore, this study failed to meet WWC single-case design standards.
In 2018, Rosenthal et al. proposed the use of sensory electrical stimulation to provide
somatosensory cueing [54]. In this paper, Rosenthal et al. hypothesized that somatosensory cueing
delivered at a fixed tempo would modify the users walking patterns and help to alleviate On-FoG.
This hypothesis was based on previously reported mechanisms responsible for the positive effects
of cueing, such as step synchronization and enhanced proprioceptive information processing [33,36].
To investigate the hypothesis Rosenthal et al. used a custom-built electrical stimulator, cueStim.
The cueStim device (105× 65× 19 mm3, 100 g) was a Bluetooth enabled voltage-controlled two-channel
electrical stimulator developed within the REMPARK (FP7 project REMPARK ICT-287677) project.
The device was worn on the waist and delivered a continuous series of electrical stimulation (ES)
bursts through the use of PALs 50 × 50 mm2 skin surface electrodes placed on the skin surface of
the hamstring or quadriceps muscle of the body side most affected by PD (Figure 15). In its then
configuration, each ES burst was delivered at a rate of 86 burst/minute and consisted of 100 ms
ramp-up time, 500 ms On time, 100 ms ramp-down time and 0 ms Off time. The amplitude of
the stimulation burst was adjusted for each participant (using a smartphone application design to
communicate with the cueStim device) such that a sensory response was elicited but that the amplitude
was not of sufficient intensity to produce a motor response.
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To investigate the effect of continuous somatosensory cueing, Rosenthal et al. carried out
home-based measurements on nine participants as they performed a self-identified walking task
with and without somatosensory cueing. The walking task aimed to reproduce daily activities which
usually elicited FoG episodes. Rosenthal et al. reported an immediate statistically significant positive
effect of somatosensory cueing on the reduction on On-FoG (58.28± 33.89%). However, it was reported
that analysis of outcome measures was only performed by one assessor, meaning the study failed to
meet WWC single-case design standards.
In the same year, Gonçalves et al. focused on investigating the optimal vibration frequency
and minimum duration of vibration to be used in a somatosensory system for PwP, to help them
to overcome FoG [92]. To investigate the hypothesis, Gonçalves et al. developed a custom-built
somatosensory cueing system (Figure 16). The system was encapsulated in a waistband and provided
tactile stimulation (pulsed vibration) at the navel, spine, right side and the left side, allowing the
system to meet the previously reported requirements for developing a robust, functional, ergonomic
and wearable system to provide vibration cueing for addressing FoG [93]. The processing unit was
developed on the Arduino Mega 2560 platform and controlled four vibration units through the Adafruit
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Industries’ DRV2605 haptic drivers. The vibration units were mini vibration motors 2.0 mm (Seed
Studio Electronic), a special type of coin vibration motor, also known as “pancake” vibrator motors
and provided vibration at a frequency range of 60–300 Hz, with an amplitude of 0.2–2.8 G. The system
was Bluetooth enabled, and both smartphone and desktop graphical interfaces were developed to
allow the wireless configuration of cueing parameters (frequency and duration of vibration). A single
12 V Lithium-Ion battery powered the system.Sensors 2019, 19, x    23  of  35 
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Figure 16. Illustration of a user wearing the continuous somatosensory cueing device developed by
Gonçalves et al. Four h ptic drivers/vibration units w e placed inside the aistband and arranged
with an interme i te spacing (15 cm) that facilitated a 76 to 110 cm waist size, while providing the
sti ulat on to the nav l, spine, right side and lef side f the waist. The waistband was designed to be
robust enough to support the electronic (ov rall weight of 458 g).
Although Gonçalves et al. did not evaluate the performance of their system on ameliorating FoG,
they did investigate the optimal vibration frequency and minimum duration of vibration required to
perceive best cueing. Based on previous works, Gonçalves et al. concluded that a vibration frequency
range between 80 and 250 Hz must be considered and carried out measurements on 15 healthy and
15 PwP participants. Although, it has been observed that PwP present a lower perception than healthy
subjects, Gonçalves et al. reported that it was possible to conclude that on average the frequency
by which all subjects present a high vibration sensitivity at waist body level, was 180 Hz. It was
also observed that greater than 250 ms of vibration duration was detectable by almost all PwP and
the healthy subjects. This was reported to be the first step of implementing their system to help
PwP ameliorating FoG. Gonçalves et al. also reported that participants did not consider the use of
the waistband uncomfortable and considered it possible to perform their daily tasks while receiving
somatosensory cueing.
In 2018, Mancini et al. further proposed the use of vibration to provide somatosensory cueing [94].
In this paper, ancini et al. hypothesized that enhancing proprioceptive stimuli, in the form of tactile
stimulation, may be useful in improving sensory integration and therefore alleviating FoG in PwP.
To test the hypothesize Mancini et al. used the VibroGait, a wearable somatosensory cueing system,
previously described in [95] (Figure 17). The system plugged into inertial sensors placed on the shins
of the user and consists of a novel controller unit (Arduino microcontroller) that senses through a
gyroscope when the foot is on the ground and activates the tactor unit to generate a vibration. The
tactor was a C-2 tactor (Engineering Acustic, Inc.) with a primary resonance in the 200–300 Hz range.
When a pulse width modulation sine-wave was sent from the control unit into the tactor, the “contactor”
oscillated perpendicular to the user’s skin. As explained by Mancini et al., this created a “point-like
sensation that is easily felt and localized”. The vibration intensity was reported to be similar to that of
a cell phone operating in vibration mode.
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Figure 17. Illustrati of a user wearing the continuous somatosensory cueing device VibroGait,
developed by Mancini et al. A haptic drivers/vibration unit was placed on rist and connected to a
control unit and inertial sensor.
To investigate the i mediate effect of continuous somatosensory cueing on Off-FoG episodes,
Mancini et al. carried out measurements on 25 participants as they performed laboratory-based
walking tasks with and without somatosensory cueing. The following measures were extracted to
objectively characterize FoG using inertial sensors and were previously described and validated in
Mancini et al. [96]; (1) FoG ratio as index of freezing severity calculated as the power spectral density
ratio between high (3–8 Hz) and low (0–3 Hz) frequencies of antero-posterior shin accelerations; and
(2) the percentage of time spent in FoG during the task, calculated as the time in which the FoG ratio
was higher than 1 (for either right or left foot). Ma cini et al. reported an immediate positive effect
of somatosensory cuei g on the percentage of time in Off-FoG during cueing (single task: 19 ± 18%,
p = 0.5; dual task: 18 ± 15%, p = 0.2). The majority of cueing studies to date validate FoG measurement
outcomes, such as the number and duration of episodes subjectively, using experienced clinical
judgment. Interestingly, t is study analyzed outcome easures through a sensor-based FoG etection
algorithm. Alt ough t is algorithm’s calculated FoG ratio has been previously shown to correlate
with a subjective clinical assessment of FoG severity [96], in the current study by Mancini et al. [94],
the results presented only reflected the percentage of time in F G. To the authors’ knowledge the
analyses of a correlation between the algorithm’s objective easure of the percentage of time in FoG
and a subjective measure of the percentage of time in FoG by two assessors (with an inter-assessor
agreement) was not performed. Therefore, we would conclude that this study failed to meet WWC
single-case design standards.
Results from subject impressions on th efficacy of somatosensory cueing on FoG while tur ing
based on a Likert scale showed that ~50% of the participants reported an improvement in FoG using
closed-loop cues
4. Discussion
This paper aimed to provide a systematic review of current cueing systems focusing on systems
with the potential to be used at home as a self-administer intervention. Both system technical
characteristics and the system efficacy are described. Of the 18 papers included in this review,
18 different cueing systems have been identified, of which eight of them (44%) have been published
since 2015, indicating that this is an expanding field of study. The general overview of the reviewed
cueing systems is presented in Tables 2–4. These tables highlight the key technical characteristics of all
the identified cueing systems.
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Table 2. Overview of auditory cueing devices.
Ref. Cueing Technology CueingMode Cueing Trigger
Cueing Stimuli




Custom-built: Small Bluetooth enabled
Linux based wearable computer and
Bluetooth enabled movement sensor.
Commercial: Wired headphones.
O. FoG detection algorithm(73.1%, 81.6%, <2 s) 1. Rhythmic, ticking (NR, NR).
Fixed
(60 bpm).































[50]  Commercial:  Metronome  (SDM300 
SAMICK).  C.  NA.  Rhythmic, tone (45–440 Hz, NR). 
Adjustable 
(40–216 bpm).  ↑ Frequency of Off‐FoG. 
[45]  Commercial:  Metronome  (Peterson 
BodyBeat).  C.  NA. 















Custom‐built:  Two  movement  sensors 
devices and Android application. 

















Frequency and duration of Off-FoG 4.
↓ Frequency and duration of Off-FoG 5.
↓ Frequency of On-FoG 4.
↓ Duration of On-FoG 3.
↑ Duration of On-FoG 3.
[44] Custom-built: Metronome.Commercial: Headphones. C. NA. Rhythmic, tone (4625 Hz, 50 ms).
Adjustable
(NR).
↓ Frequency of EoD-FoG.
↓ Duration of EoD-FoG.
[50] Commercial: Metronome (SD 300SAMICK). C. NA. Rhythmic, tone (45–440 Hz, NR).
Adjustable
(40–216 bpm). ↑ Frequency of Off-FoG.
[45] Commercial: Metronome (PetersonBodyBeat). C. NA.
Rhythmic, rimshot, clave, wood Block or
beep (NR, N ).
Adjustable
(10–280 bpm). ↓ Percentage of Off-FoG per walking task.
[82]
Custom-built: FoG detection device and
Android application. Commercial:
Smartphone and wireless ear-set.
O. FoG detection algorithm(82.2%, 92.8%, 3.2 s) 1.
Rhythmic, ticking, musical beats,




Custom-built: Two movement sensors
devices and Android application.
Commercial: Smartphone and wired
headphones. (GaitAssist)
O. FoG detection algorithm(97.1%, 26.5%, 0.5 s) 2. Rhythmic, ticking (NR, NR).
Adjustable
(NR).
↓ Frequency of FoG.
↓ Duration of FoG.
[48] Custom-built: Android application.Commercial: Google Glass. O. NA. Rhythmic, NR (NR, NR).
Adjustable
(NR).































[50]  Commercial:  Metronome  (SDM300 
SAMICK).  C.  NA.  Rhythmic, tone (45–440 Hz, NR). 
Adjustable 
(40–216 bpm).  ↑ Frequency of Off‐FoG. 
[45]  Commercial:  Metronome  (Peterson 
BodyBeat).  C.  NA. 















Custom‐built:  Two  movement  sensors 
devices and Android application. 

















Frequency and duration of EoD-FoG.
↓ Frequency of EoD-FoG 6.
NR = not reported; NA = not applicable; C = Continuous; O = On-demand; ↓ = reduced; ↑ = increased;































[50]  Commercial:  Metronome  (SDM300 
SAMICK).  C.  NA.  Rhythmic, tone (45–440 Hz, NR). 
Adjustable 
(40–216 bpm).  ↑ Frequency of Off‐FoG. 
[45]  Commercial:  Metronome  (Peterson 
BodyBeat).  C.  NA. 















Custom‐built:  Two  movement  sensors 
devices and Android application. 

















= no change. 1 sensitivity, specificity, lag time. 2 sensitivity, false negative,
lag time. 3 For one participant. 4 For two participants. 5 For three participants. 6 Only during complex 360◦ turns.
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Table 3. Overview of visual cueing devices.









C. NA. Optical Flow, moving virtualcheckerboard-tiled (NR).
Dynamic (Automatically
adjusts to gait speed). ↓ FOGQ score.
[43] Custom-built: Walking cane withattached laser. C. NA. Static, horizontal laser line (green or red). NA.
↓ Frequency of On-FoG and Off-FoG
(green laser).
↓ Frequency of On-FoG (red laser).
↑↓ Frequency of Off-FoG (red laser). 1
[45,57] Commercial: U-Step walking cane. C. Weight-activated switch. Static, horizontal laser line (red). NA. ↓ Percentage of Off-FoG per walking task.
[49,57] Commercial: U-Step walkingstabilizer. O. Push button switch. Static, horizontal laser line (red). NA. ↑↓ Frequency of On-FoG.
2






Optical Flow or Rhythmic, moving virtual
vertically oriented lines or flashing virtual
screen (red).
Adjustable.































[50]  Commercial:  Metronome  (SDM300 
SAMICK).  C.  NA.  Rhythmic, tone (45–440 Hz, NR). 
Adjustable 
(40–216 bpm).  ↑ Frequency of Off‐FoG. 
[45]  Commercial:  Metronome  (Peterson 
BodyBeat).  C.  NA. 















Custom‐built:  Two  movement  sensors 
devices and Android application. 

















Frequency and duration of EoD-FoG.






O. FoG detection algorithm(97%, 88%, 1.1 s).
Optical Flow, moving virtual horizontal
lines (blue).
Dynamic (Automatically
adjusts to gait speed). NR.
[51] Custom-built: Shoe attachment withlaser (Laser Shoes). C. Heel strike switch. Static, horizontal laser line (red). NA.
Frequency of On-FoG and Off-FoG.
↓ Percentage of time in On-FoG and
Off-FoG.
NR = not reported; NA = not applicable; C = Continuous; O = On-demand; ↓ = reduced; ↑ = increased;































[50]  Commercial:  Metronome  (SDM300 
SAMICK).  C.  NA.  Rhythmic, tone (45–440 Hz, NR). 
Adjustable 
(40–216 bpm).  ↑ Frequency of Off‐FoG. 
[45]  Commercial:  Metronome  (Peterson 
BodyBeat).  C.  NA. 















Custom‐built:  Two  movement  sensors 
devices and Android application. 

















= no change. 1 Negative effect during 15.2 m task and positive effect during
turning task. 2 Negative effect during walking task 1 and 2 and positive effect during walking task 3.
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Table 4. Overview of somatosensory cueing devices.




Type, Somatosensory (Frequency, Duration)
Cueing Tempo
Configuration Effectiveness
[45] Commercial: Metronome(Peterson BodyBeat). C. NA. Rhythmic, vibrations (NR, NR).
Adjustable
(10–280 bpm).
↓ Percentage of walking task with
Off-FoG.
[54] Custom-built: Two channelelectrical stimulator (cueStim). C. NA. Rhythmic, Biphasic electrical pulses (NR, 500 ms).
Fixed
(86 bpm) ↓ Frequency of On-FoG.
[92] Custom-built: Vibratingwaistband. C. NA. Rhythmic, vibrations (NR, 100–1000 ms).
Adjustable
(80–250 Hz). NA
[94] Custom-built: Vibrating system(VibroGait). C. NA. Rhythmic, vibrations (200–300 Hz, NR)
Dynamic (Automatically
adjusts to gait speed). ↓ Frequency of and time spent in Off-FoG.
NR = not reported; NA = not applicable; C = Continuous; ↓ = reduced.
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Since 2010, auditory cueing systems have evolved from the development of custom-built
technologies (as presented by Bachlin and Arias) to the use of stand-alone commercial devices
(i.e., digital metronomes), to the integration of custom-built devices (i.e., movement sensors) with
commercially available units such as smartphones and smartglasses. Similarly, visual cueing
systems have evolved from custom-built technologies to the use of stand-alone commercial devices
(i.e., the U-Step Lasercane and the U-Step walking stabilizer), and the integration of custom-built
Android applications with commercially available smartglasses (i.e., Google Glass and Epson BT200).
Somatosensory cueing systems have not had the time to evolve in parallel with auditory or visual
cueing systems as a method to ameliorate FoG. However, both novel custom-built technologies and
stand-alone commercial devices (i.e., digital vibrating metronome) have been utilized to investigate
somatosensory cueing.
From the 18 identified cueing systems, five of them provided auditory cueing, seven of
them provided visual cueing, three of them provided somatosensory cueing and a further three
provided dual cueing modalities (two auditory and visual cueing systems and one auditory
and somatosensory cueing system). Auditory cueing has been shown to ameliorate EoD-FoG
episodes [44,48], Off-FoG episodes [45] and On-FoG episodes [75]. Visual cueing has been shown
to ameliorate Off-FoG episodes [42,43,45,51] and On-FoG episodes [42,43,49,51,55]. The effect of
somatosensory cueing has also been shown to ameliorate Off-FoG episodes [45,94] and On-FoG
episodes [54]. However, due to the limited number of studies [45,48] that directly compared different
cueing modalities, further investigation will be required to establish which modality is the most
effective in different circumstances.
Cueing systems have been described that are capable of providing Continuous or On-demand
cueing. Of the 18 identified cueing systems, 13 of them (72%) have been characterized as Continuous
cueing systems, five of them (28%) as On-demand cueing systems. Continuous cueing systems provide
cueing continuously even if not required and predominantly aim to prevent FoG from occurring.
An advantage of Continuous cueing systems is the simple technological requirements of the system
and the ease of application, which typically consists of a single device (i.e., digital metronome or
lasercane). However, as a result of the continuous delivery of the stimulus, these systems may prove to
be less effective during extended periods of usage due to possible habituation and compliance issues.
Due to the identified weaknesses of Continuous cueing, On-demand cueing was proposed and
provides cueing only when required (during a FoG episode) and predominantly aims to relieve FoG
episodes by reducing their duration. In comparison to Continuous cueing systems, On-demand
systems are more sophisticated and predominantly incorporate a FoG detection algorithm [56,71,82,85].
A key characteristic of On-demand cueing systems relates to the sensitivity and specificity and lag
time (time between the appearance of a FoG episode and its detection) parameters of its FoG detection
algorithm. These parameters define the performance of the algorithm. However, it is unclear which
parameters are most important to the overall efficacy of the systems. In 2010, Bachlin and colleagues
implemented a real-time FoG detection algorithm with an average sensitivity of 73.1% and specificity
of 81.6% at a lag time >2 s [75]. For some patients, this low specificity value resulted in the patients
requesting to hear the auditory cueing less often, and for some patients, the low sensitivity value
resulted in the patients requesting to hear the auditory cueing more often and was reported to affect the
overall acceptance of the system. Interestingly, Bachlin et al. suggested that sensitivity and specificity
are equally important [72], while more recently, Kwon et al. reported that sensitivity is more important
than specificity, suggesting that low false negatives matter more than low false positives [97]. However,
due to refinements in FoG detection algorithm designs and increased processing power of some cueing
systems, recent On-demand cueing systems have reported sensitivity values of 82.2% [82], 97% [56]
and 97.1% [85]. In addition, specificity values of 92.8% [82] and 88% [56] were achieved. The cueing
system presented by Mazilu et al. operated at a lag time of 0.5 s [85], this was a significantly lower lag
time than previous systems 1.1 s [56] <2 s [75] and 3.2 s [82]. However, a short lag time typically results
in reduced specificity. The need for such a short lag time is up for discussion, and it may be suggested
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that providing cueing for FoG episodes that last only a short time may not be required, as these FoG
episodes may not be troublesome for PwP.
Interestingly, Bunting-Perry et al. evaluated an On-demand cueing system that was self-activated.
Unlike other On-demand cueing systems the user activated/deactivated cueing by pressing a button,
therefore the sensitivity and specificity and lag time of the system was dependent only on the user’s
ability to detect FoG and press a button. However, the concurrent use of the walking stabilizer and
the self-activation of cueing was suggested to represent a dual-task that may reduce the effect of
self-activated cueing.
Whether Continuous cueing is more effective than On-demand at ameliorating FoG, or vice versa,
remains to be established. Continuous cueing systems have been shown to reduce the frequency
of EoD-FoG episodes [44,48], Off-FoG episodes [42,43,45,51], and On-FoG episodes [42,45,51,54,55].
Interestingly, Zhao et al. demonstrated that their Continuous cueing system was only effective at
reducing the frequency of EoD-FoG episodes while the PwP were performing turning maneuvers with
auditory cueing and had no effect during other walking scenarios [49]. In the same study, it was also
shown that the Continuous cueing system did not affect the duration of EoD-FoG episodes. However,
Arias and Cudeiro demonstrated that their Continuous auditory cueing system might have a positive
effect on the duration of EoD-FoG episodes [44]. In comparison, On-demand cueing systems have been
shown, in some cases, to reduce the duration and frequency of FoG episodes for some PwP. However,
results are limited and based on small participant cohorts [49,75,85].
Another key characteristic of cueing systems is the cueing stimulus and the information that it
presents. In the last decade, cueing systems have used three different types of cueing stimuli; rhythmic,
static and optic flow. These types of stimuli may provide temporal, spatial, and/or proprioceptive
information and aim to ameliorate FoG through different mechanisms, which remains to be established.
Of the 18 identified cueing systems, nine of them (50%) have been characterized as rhythmic cueing
systems, five of them (28%) as static systems, two of them (11%) as optic flow systems, and two of
them (11%) as dual systems (one rhythmic/static and one rhythmic/optic flow).
Auditory and somatosensory cueing systems have predominantly provided rhythmic cueing
stimuli. These systems deliver cueing rhythmically at a set tempo that is either fixed [54,75],
adjustable [44,45,49,82,85,92] or dynamic [94]. Auditory stimuli have been provided in the form of
sounds at a given frequency and duration. Similarly, somatosensory stimuli have been provided in the
form of vibrations [45,92,94] or electrical stimulation [54] at a given frequency and duration. However,
detailed information on the stimulus produced was not presented for all systems. The importance
of presenting details of the stimuli used should not be overlooked as recent evidence suggests that
improvements to gait in PwP are directly influenced by the specific nature of cueing stimuli [59,98].
The majority of visual cueing systems have used static cueing stimuli [42,43,45,49,51,55]. However,
a limited number of systems have provided optic flow [48,56,61] or rhythmic [48,55] cueing stimuli.
A static visual stimulus has been provided in the form of a horizontal laser line projected on the ground.
Interestingly, Bryant et al. demonstrated that the color of the laser line may affect the efficacy of the
cueing systems [43]. It was suggested that a green laser line was more effective than a red laser line
at ameliorating FoG. In an alternative method of visual cueing, an optical flow visual stimulus has
been provided through smartglasses in the form of moving virtual checkboards [61], moving vertical
red lines [48] or moving horizontal blue lines [56] that may enhance the perception of movement. In a
similar fashion to rhythmic cueing stimuli, these systems deliver cueing at a set tempo that was either
adjustable [48] or dynamic [55,61]. A rhythmic visual stimulus has been provided through a laser cane
in the form of a flashing horizontal laser line projected on the ground [55] or through smartglasses in
the form of a virtual flashing screen [48]. The most effective type of visual cueing stimuli remains to
be established. In fact, considering that the majority of the cueing systems identified in this review
were evaluated in a laboratory setting, with limited results often reported, many questions remain on
the effectiveness of such systems to ameliorate FoG in a home setting and subsequently improve QoL
for PwP.
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It remains to be seen which characteristic of cueing systems will prove to be most appropriate in
the long-run. This is perhaps expected for a growing field of research and may be due to experimental
nature of the cueing studies and the lack of a gold standard for evaluating the effect of cueing systems
on FoG, which resulted in the adoption of various cueing technologies and evaluation methodologies
making comparisons between systems difficult.
The limited number of statistically significant findings is disappointing. For example, only Arias
et al., Barthel et al., Buated et al., Bryant et al., McCandless et al., Rosenthal et al. and Tang et al.
reported statically significant improvements in outcome measures. Additionally, only of one the
studies (Zhao et al.) passed the WWC quality test for single case study design, indicating that more
attention and rigor needs to be applied to the design of studies used to evaluate these technologies.
Another consideration is the cost and usability of these cueing devices. The cost of electronics
hardware continues to come down and when compared to possible surgical interventions, the cost
of these systems should not be a significant barrier. The usability of these systems is however a very
important consideration and can be best achieved with user-centered design approaches, where the
user community is a key stakeholder in the design process. Previous work by our group has shown
that good usability can be achieved with older adults using this approach [99–102].
There is potential for future work to exploit to full benefit of cueing for FoG in PD, through
the use of new technologies as they emerge. While it is challenging to perform the kind of clinical
evaluations described in this review, there is a particular requirement for more thorough validation of
these systems as much work to date has involved low participant numbers, with studies carried out
in laboratory environments rather than home environments. There is also scope in future studies for
enhanced experimental design so that the robustness of the evidence being produced is enhanced.
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